Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Fens, A. C. Roldaan, E. H. Bel, P. J. Sterk (Amsterdam, Den Haag, Netherlands). External validation of exhaled breath molecular profiling in identifying COPD and asthma. Eur Respir J 2010; 36: Suppl. 54, 3842

Member's Comments

No comment yet.

Related content which might interest you: Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath Source: ERS Lung Science Conference 2016 Year: 2016 Breath analysis for discriminating and phenotyping COPD and asthma Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances Year: 2010 Assessment of virus-induced wheeze by exhaled breath molecular profiling in pre-school children, the EUROPA-study Source: Annual Congress 2010 - Paediatric asthma risk factors Year: 2010 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Exhaled breath molecular profiling in measuring inflammatory status in COPD Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019 NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients Source: International Congress 2017 – Management of COPD Year: 2017 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Exhaled breath condensate analysis in diagnostics of occupational asthma and rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006 The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Metabonomics applied to exhaled breath condensate in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 123s Year: 2006 Clinical usefulness of exhaled breath temperature in asthma control Source: Eur Respir J 2007; 30: Suppl. 51, 64s Year: 2007